TD Cowen Cuts Teladoc Health (NYSE:TDOC) Price Target to $9.00

Teladoc Health (NYSE:TDOC) had its price target decreased by TD Cowen from $15.00 to $9.00 in a research report report published on Thursday, Benzinga reports. TD Cowen currently has a hold rating on the health services provider’s stock.

TDOC has been the subject of a number of other research reports. Oppenheimer reduced their target price on Teladoc Health from $21.00 to $17.00 and set an outperform rating for the company in a report on Thursday. Wells Fargo & Company cut their price target on Teladoc Health from $17.00 to $15.00 and set an equal weight rating for the company in a research note on Monday, April 29th. DA Davidson cut their price target on Teladoc Health from $12.00 to $8.00 and set a neutral rating for the company in a research note on Thursday. Needham & Company LLC reaffirmed a hold rating on shares of Teladoc Health in a research note on Friday, April 26th. Finally, Bank of America cut their price target on Teladoc Health from $16.50 to $13.50 and set a neutral rating for the company in a research note on Tuesday, May 14th. Fourteen analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, Teladoc Health currently has a consensus rating of Hold and a consensus price target of $14.44.

Teladoc Health Price Performance

Teladoc Health stock traded down $0.51 during midday trading on Thursday, reaching $7.44. The company’s stock had a trading volume of 1,455,289 shares, compared to its average volume of 5,436,324. Teladoc Health has a fifty-two week low of $7.31 and a fifty-two week high of $26.00. The company has a debt-to-equity ratio of 0.67, a quick ratio of 3.74 and a current ratio of 3.82. The stock’s 50 day simple moving average is $9.88 and its 200 day simple moving average is $13.61. The firm has a market capitalization of $1.26 billion, a PE ratio of -5.64 and a beta of 0.93.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, Director Karen L. Daniel sold 9,834 shares of Teladoc Health stock in a transaction dated Thursday, May 23rd. The stock was sold at an average price of $11.90, for a total value of $117,024.60. Following the completion of the sale, the director now owns 36,995 shares in the company, valued at approximately $440,240.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders sold 15,388 shares of company stock worth $178,225 in the last 90 days. 0.95% of the stock is owned by company insiders.

Institutional Trading of Teladoc Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its holdings in shares of Teladoc Health by 11.8% during the 4th quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider’s stock worth $377,451,000 after purchasing an additional 1,855,480 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of Teladoc Health by 25.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,834,422 shares of the health services provider’s stock worth $82,636,000 after purchasing an additional 767,999 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in shares of Teladoc Health by 6.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,654,116 shares of the health services provider’s stock worth $35,646,000 after purchasing an additional 104,531 shares during the period. Bank of New York Mellon Corp grew its holdings in shares of Teladoc Health by 1.7% during the 2nd quarter. Bank of New York Mellon Corp now owns 916,129 shares of the health services provider’s stock worth $8,960,000 after purchasing an additional 14,910 shares during the period. Finally, Allianz Asset Management GmbH grew its holdings in shares of Teladoc Health by 15.4% during the 4th quarter. Allianz Asset Management GmbH now owns 604,238 shares of the health services provider’s stock worth $13,021,000 after purchasing an additional 80,805 shares during the period. Hedge funds and other institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.